作者: 強(qiáng)化 時(shí)間: 2025-3-21 20:59
Feed Evaluation, Past and Present,umours, (3) gynaecological tumours. Several pooled data (diagnostic and prognostic data), clinical settings (e.g. staging, restaging, treatment evaluation) and radiotracers as fluorine-18 fluorodeoxyglucose (.F-FDG), radiolabelled choline and prostate-specific membrane antigen (PSMA) were considered.作者: Incumbent 時(shí)間: 2025-3-22 02:28
The Built Environment in Australia,of them. In this chapter were only considered recent systematic reviews and meta-analyses concerning the use of PET or PET/CT with .F-FDG in haematological malignancies dividing the results by the main areas of application.作者: glisten 時(shí)間: 2025-3-22 04:33 作者: Medley 時(shí)間: 2025-3-22 12:29 作者: 高興去去 時(shí)間: 2025-3-22 15:53
Evidence-Based PET for Brain Tumoursdard neuroimaging method used for diagnosis of brain tumours, for performing stereotactic biopsy and surgical planning in neuro-oncology [2]. Currently, hybrid imaging techniques as PET/CT and PET/MRI, providing a combination of both functional and morphological information, may be useful methods for early diagnosis of brain tumours [1, 2].作者: 高興去去 時(shí)間: 2025-3-22 17:10
Book‘‘‘‘‘‘‘‘ 2020the use of PET in cardiology, in infectious and inflammatory diseases, and in neurology, respectively...Given its scope and the wealth of information it provides, the book will be an invaluable tool for clinicians with various specialties, as well as international scientific societies interested to the recent evidence-based data about PET..作者: pineal-gland 時(shí)間: 2025-3-22 22:53 作者: groggy 時(shí)間: 2025-3-23 03:19 作者: 貨物 時(shí)間: 2025-3-23 07:38 作者: archenemy 時(shí)間: 2025-3-23 11:41 作者: floodgate 時(shí)間: 2025-3-23 16:37 作者: 一夫一妻制 時(shí)間: 2025-3-23 22:03 作者: BROW 時(shí)間: 2025-3-24 01:38 作者: 整頓 時(shí)間: 2025-3-24 04:26
https://doi.org/10.1007/978-3-319-52333-03]. The number of systematic reviews and meta-analyses on nuclear medicine diagnostic and prognostic studies is increasing [4, 5]. In the current chapter, a practical guideline has been prepared for the researchers who intend to perform a systematic review or meta-analysis of diagnostic and prognostic studies.作者: Apraxia 時(shí)間: 2025-3-24 08:15 作者: 類似思想 時(shí)間: 2025-3-24 10:41
A Practical Guideline on Diagnostic and Prognostic Meta-Analyses3]. The number of systematic reviews and meta-analyses on nuclear medicine diagnostic and prognostic studies is increasing [4, 5]. In the current chapter, a practical guideline has been prepared for the researchers who intend to perform a systematic review or meta-analysis of diagnostic and prognostic studies.作者: Ptsd429 時(shí)間: 2025-3-24 18:36
https://doi.org/10.1007/978-3-030-47701-1Open Access; Nuclear Medicine; Meta-analysis; Diagnosis; Tumor; Infection; Diagnostic Radiology作者: Folklore 時(shí)間: 2025-3-24 20:15 作者: 稱贊 時(shí)間: 2025-3-25 02:43
http://image.papertrans.cn/e/image/317586.jpg作者: 要求比…更好 時(shí)間: 2025-3-25 04:49 作者: Intuitive 時(shí)間: 2025-3-25 09:13
https://doi.org/10.1007/BFb0071780valuation of breast cancer (BC) patients. This chapter provides an overview of the current evidence-based data on the usefulness of PET/CT (using .F-FDG and other radiotracers) for different indications in patients with BC.作者: 少量 時(shí)間: 2025-3-25 12:01 作者: 改變 時(shí)間: 2025-3-25 17:01 作者: 是他笨 時(shí)間: 2025-3-25 23:19 作者: Gnrh670 時(shí)間: 2025-3-26 02:57
Evidence-Based PET for Cutaneous, Musculoskeletal and Unknown Primary TumoursPET/CT is extremely useful method in cutaneous and musculoskeletal tumours. In this chapter, the evidence from the literature concerning PET or PET/CT in melanoma, sarcomas, bone metastases, cancer of unknown primary (CUP) and paraneoplastic syndromes were analysed.作者: 遍及 時(shí)間: 2025-3-26 06:39 作者: 軟弱 時(shí)間: 2025-3-26 09:29 作者: Serenity 時(shí)間: 2025-3-26 16:10 作者: Genetics 時(shí)間: 2025-3-26 17:39
Current Topics in Veterinary Medicinenges in oncological patients, including those with brain tumours. These functional changes usually occur before the development of morphological changes detected by conventional radiological imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) [1]. MRI is the stan作者: Encapsulate 時(shí)間: 2025-3-27 00:22
The Role of Proline in Energy Metabolism,cinoma (HNSCC) represents the majority of HNC [1, 2]. Nodal involvement is frequent in HNC patients, whereas distant metastases are rather uncommon at the time of initial diagnosis and are found approximately in 10% of patients. There is a clear association with lifestyle and factors as alcoholism, 作者: jagged 時(shí)間: 2025-3-27 03:28
Applications to Problems in Fluid Mechanics,ly clinical practice for the evaluation of thoracic malignancies. This chapter provides an overview of the current evidence-based data on the usefulness of PET/CT for the evaluation of patients with thoracic tumours including lung cancer, pleural and thymic tumours, and esophageal cancer.作者: Additive 時(shí)間: 2025-3-27 08:19
https://doi.org/10.1007/BFb0071780valuation of breast cancer (BC) patients. This chapter provides an overview of the current evidence-based data on the usefulness of PET/CT (using .F-FDG and other radiotracers) for different indications in patients with BC.作者: 征稅 時(shí)間: 2025-3-27 13:30 作者: 侵蝕 時(shí)間: 2025-3-27 13:58 作者: 搬運(yùn)工 時(shí)間: 2025-3-27 17:52
Households: Trends and Perspectivespredict the exact tumour extent, foremost in metastatic disease. Anatomical imaging as computed tomography (CT) and magnetic resonance imaging (MRI) serves as the first-line modality in the locoregional staging of these tumours. Compared with anatomical imaging, PET shows both high sensitivity and s作者: Ruptured-Disk 時(shí)間: 2025-3-28 01:44
https://doi.org/10.1007/978-3-030-84993-1or infectious diseases. These changes usually occur before clinical onset of symptoms and before the development of anatomical changes detected by radiological techniques [1, 2]. Currently, hybrid imaging techniques as positron emission tomography/computed tomography (PET/CT) may provide functional 作者: 進(jìn)步 時(shí)間: 2025-3-28 02:12
Saeed P. Langarudi,Michael J. Radzickin represented by the validation of diagnostic biomarkers able to demonstrate the presence of pathological mechanisms, alteration in neurotransmission as well as to predict disease progression [1, 2]. The use of PET with different tracers as well as other imaging biomarkers support the etiological di作者: debris 時(shí)間: 2025-3-28 08:49
Introduction to Different PET Radiopharmaceuticals and Hybrid Modalities (PET/CT and PET/MRI)radionuclides and consists in the conversion of a proton into a neutron with the simultaneous emission of a positron (.+) and a neutrino (.). The positron has a very short lifetime, and after the annihilation with an electron simultaneously produces two high-energy photons (.?=?511?keV) in approxima作者: 不感興趣 時(shí)間: 2025-3-28 10:41
A Practical Guideline on Diagnostic and Prognostic Meta-Analysesc reviews and meta-analyses plays an important role in evidence based medicine. Essentially systematic reviews and meta-analyses are the cornerstone of evidence based practice. The main difference between a systematic review and a narrative review is the clear method of the former including a clear 作者: acrobat 時(shí)間: 2025-3-28 17:13 作者: 剝削 時(shí)間: 2025-3-28 22:27
Evidence-Based PET for Head and Neck Tumourscinoma (HNSCC) represents the majority of HNC [1, 2]. Nodal involvement is frequent in HNC patients, whereas distant metastases are rather uncommon at the time of initial diagnosis and are found approximately in 10% of patients. There is a clear association with lifestyle and factors as alcoholism, 作者: MELON 時(shí)間: 2025-3-29 02:12
Evidence-Based PET for Thoracic Tumoursly clinical practice for the evaluation of thoracic malignancies. This chapter provides an overview of the current evidence-based data on the usefulness of PET/CT for the evaluation of patients with thoracic tumours including lung cancer, pleural and thymic tumours, and esophageal cancer.作者: Yourself 時(shí)間: 2025-3-29 03:40
Evidence-Based PET for Breast Cancervaluation of breast cancer (BC) patients. This chapter provides an overview of the current evidence-based data on the usefulness of PET/CT (using .F-FDG and other radiotracers) for different indications in patients with BC.